Intensity-modulated radiation therapy has become the most commonly used type of radiation in prostate cancer, but research from UNC suggests that the therapy may not be more effective than older, less expensive forms of radiation therapy in patients who have had a prostatectomy.
An Ashe County man witnesses random acts of kindness daily – both as a deliberate and often anonymous giver and as an ever-grateful receiver – while in Chapel Hill for the treatment of non-Hodgkin lymphoma.
The antibody, created at the University of North Carolina, is the first therapeutic discovered that targets a protein known as SFRP2.
Researchers at the University of North Carolina have discovered that transcription factors regulating the levels of oxygen in the blood also play a role in the spread of the skin cancer melanoma.
A Dare County real estate agent refuses to let a breast cancer diagnosis and its treatment detract from her trademark sense of humor and constant outreach to others.
In the first application of this approach, the UNC researchers showed how a protein called Src kinase influences the way cells extend and move, a previously unknown role that is consistent with the protein’s ties to tumor progression and metastasis.
A team led by Dr. Stanley Lemon discovered that hepatitis A virus does not have an envelope when found in the environment, but acquires one from the cells that it grows in within the liver. It circulates in the blood completely cloaked in these membranes.
Tammy Cotton, a housekeeper who works at UNC Lineberger Comprehensive Cancer Center and the Thurston Bowles building, and James R. “Bud” Harper, retired associate dean of medical alumni affairs, received awards. The Massey Award is one of the most coveted distinctions the University gives faculty and staff.
The study is the first published population-based examination of racial disparities in prostate cancer treatment delay.
Researchers in the lab of Carol Otey, PhD, found that the protein palladin enhances the ability of cancer-associated fibroblasts (CAFs) to assemble organelles known as invadopodia to break down the barriers between cells and create pathways for tumors to spread throughout the body.
Dr. Oliver Smithies, Weatherspoon Eminent Distinguished Professor in the Department of Pathology and Laboratory Medicine, is a 2007 Nobel Laureate whose work revolutionized research into the genetic basis of cancer.
A Craven County woman is diagnosed with a rare soft-tissue cancer on her 35th wedding anniversary. Together, she and her husband are raising awareness about cancer while she fights the disease.
A research team directed by Professors John Sondek, PhD, UNC School of Medicine and William Janzen, UNC Eshelman School of Pharmacy, has been awarded a two-year grant from the Community United for Research and Education of Ocular Melanoma (CURE OM) to identify inhibitors of an oncogene found in the majority of melanomas of the eye.
A team of scientists, including Neil Hayes, MD, MPH, from UNC Lineberger Comprehensive Cancer Center, report results of a clinical trial comparing treatments for this cancer, the seventh most common tumor type in the United States.
The probe, named UNC1215, will provide researchers with a powerful tool to investigate the function of malignant brain tumor (MBT) domain proteins in biology and disease.
A team lead by Xian Chen of UNC mapped the complex interactions of proteins that control inflammation at the molecular level.
By analyzing data from DNA microarrays, a UNC-led team has completed a study that confirms the presence of four molecular classes of the disease and extends previous results by suggesting that there may be an underlying connection between the molecular classes and observed genomic events, some of which affect known cancer genes.
A career U.S. Army Special Forces officer from Robeson County takes on cancer with the same toughness he uses on the battlefield. At UNC Hospitals he finds his dream team -- including his son, who lost both legs while serving in Afghanistan -- to help in the fight.
A team lead by Charles Perou, PhD, of UNC Lineberger Comprehensive Cancer Center, examined more than 1,700 breast tumors, including 412 triple negative (TN) breast cancers, and concluded that triple-negative cancers, and basal-like breast cancers should not be considered as a single type.
An international team of scientists led by the University of North Carolina has published a study evaluating different ways of helping men consider their values about PSA screening. They report that the decision-making process was influenced by the format in which information was presented.